Anti-SARS CoV spike glycoprotein antibody, mouse monoclonal (3A2)

Product#: FNK-65-101
$211.54
Availability:
Ships in 1-2 Weeks

Anti-SARS CoV spike glycoprotein antibody, mouse monoclonal (3A2)


General Information

Cat. No. :FNK-65-101
Size :50 ug
Host Species Mouse
Isotype IgG2b (κ)
Clone 3A2 
Immunogen Formaldehyde inactivated SARS Coronavirus.
Reactivity Reacts with spike protein of SARS-CoV but does not with SARS-CoV2 and MERS virus.
Purification ProteinA-purified IgG
Application  
  1. Western Blotting (0.1~0.3 μg/ml)
  2. Immuno-Fluorescence staining (~1 μg/ml)
  3. Flow Cytometry (assay dependent)
  4. Neutralization (assay dependent)
Storage Ship at 4℃ or -20℃ and store at -20℃. Do not freeze
Form 1 mg/ml in PBS (-), 50% glycerol, filter-sterilized, azide free
Data Link UniProKB: P59594
 

Background

A novel type of coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Spike glycoprotein is essential for the infection and directly binds to the virus receptor, ACE2 (Angiotensin-Converting Enzyme 2). The spike protein consisting of 1181 amino acids, which migrates at 200 kDa position on SDS-PAGE (Fig. 2), the larger size due to its glyco-chains.
 

Anti-SARS.png
Fig 1. Identification of the spike antigen in the SARS virus infected cells by indirect immunostaining with 3A2 antibody at 1/1,000 dilution. (a) Uninfected Vero E6 cells. Fig 2. Identification of the spike glycoprotein in the crude extract of the SARS virus infected cells by Western blotting using 3A2 antibody at 1/10,000 dilution.
 



References 
This product has been used in the following Publications.

  1. Yamate M et al. Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrome coronavirus. Microbes Infect. 2005 Dec;7(15):1530-40.PMID: 16269264 IF, FC
  2. Yamashita M et al. Susceptibility of human and rat neural cell lines to infection by SARS-coronavirus. Biochem Biophys Res Commun. 2005 Aug 19;334(1):79-85. PMID:15992768. IF
  3. Li GM et al. Reduced incorporation of SARS-CoV spike protein into viral particles due to amino acid substitutions within the receptor binding domain. Jpn J Infect Dis. 2008 Mar;61(2):123-7. PMID:18362400 WB, Neutralization


 

Logo_BioAcademia.png

Satisfaction
Quality Rating
Value Rating
Style Rating
X